Cleared Traditional

K230648 - Access hsTnI (FDA 510(k) Clearance)

Dec 2023
Decision
270d
Days
Class 2
Risk

K230648 is an FDA 510(k) clearance for the Access hsTnI. This device is classified as a Immunoassay Method, Troponin Subunit (Class II - Special Controls, product code MMI).

Submitted by Beckman Coulter, Inc. (Chaska, US). The FDA issued a Cleared decision on December 4, 2023, 270 days after receiving the submission on March 9, 2023.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1215.

Submission Details

510(k) Number K230648 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 09, 2023
Decision Date December 04, 2023
Days to Decision 270 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code MMI — Immunoassay Method, Troponin Subunit
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1215

Similar Devices — MMI Immunoassay Method, Troponin Subunit

VITROS Immunodiagnostic Products hs Troponin I Reagent Pack
K252393 · Ortho-Clinical Diagnostics, Inc. · Oct 2025
Access hsTnI
K243483 · Beckman Coulter, Inc. · Aug 2025
Access hsTnI
K242870 · Beckman Coulter, Inc. · Jun 2025
Atellica® IM High-Sensitivity Troponin I (TnIH)
K241165 · Siemens Healthcare Diagnostics, Inc. · Jul 2024
Access hsTnI
K222881 · Beckman Coulter, Inc. · Dec 2023
Elecsys Troponin T Gen 5
K201441 · Roche Diagnostics · Sep 2021